Diabetes Associated Ophthalmic Treatment Market, Global Outlook and Forecast 2022-2028
Diabetic eye disease is a group of eye problems that can affect people with diabetes. These conditions include diabetic retinopathy, diabetic macular edema, cataracts, and glaucoma. An increase in the incidence of diabetes due to aging, obesity, and an unhealthy lifestyle is one of the factors contributing to the growth of the market for diabetes-associated ophthalmic.
This report contains market size and forecasts of Diabetes Associated Ophthalmic Treatment in Global, including the following market information:
Global Diabetes Associated Ophthalmic Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetes Associated Ophthalmic Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dry Eye Syndrome Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetes Associated Ophthalmic Treatment include Alcon, Johnson & Johnson Services, Inc., Bausch Health, F. Hoffmann-La Roche Ltd, Allergan, Bayer AG, Santen Pharmaceutical Co. Ltd., Novartis AG and Pfizer, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Associated Ophthalmic Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Associated Ophthalmic Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, by Type, 2021 (%)
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, by End User, 2021 (%)
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Diabetes Associated Ophthalmic Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetes Associated Ophthalmic Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Diabetes Associated Ophthalmic Treatment in Global, including the following market information:
Global Diabetes Associated Ophthalmic Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Diabetes Associated Ophthalmic Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Dry Eye Syndrome Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Diabetes Associated Ophthalmic Treatment include Alcon, Johnson & Johnson Services, Inc., Bausch Health, F. Hoffmann-La Roche Ltd, Allergan, Bayer AG, Santen Pharmaceutical Co. Ltd., Novartis AG and Pfizer, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Associated Ophthalmic Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diabetes Associated Ophthalmic Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, by Type, 2021 (%)
- Dry Eye Syndrome
- Glaucoma
- Eye Allergy & Infection
- Diabetic Retinopathy
- Diabetic associated Macular Degeneration
- Uveitis
- Cataract
- Diabetic Macular Edema
- Others
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, by End User, 2021 (%)
- Hospitals
- Ophthalmic Centers
- Ambulatory Surgical Centers
- Others
Global Diabetes Associated Ophthalmic Treatment Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Diabetes Associated Ophthalmic Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Diabetes Associated Ophthalmic Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Alcon
- Johnson & Johnson Services, Inc.
- Bausch Health
- F. Hoffmann-La Roche Ltd
- Allergan
- Bayer AG
- Santen Pharmaceutical Co. Ltd.
- Novartis AG
- Pfizer, Inc.
- Genentech, Inc.
- Carl Zeiss Meditec
- Lumenis
- Ellex Medical Lasers Ltd.
- IRIDEX Corp.
- Topcon Corp.
- Abbott Medical Optics
- Quantel
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Diabetes Associated Ophthalmic Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by End User
1.3 Global Diabetes Associated Ophthalmic Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DIABETES ASSOCIATED OPHTHALMIC TREATMENT OVERALL MARKET SIZE
2.1 Global Diabetes Associated Ophthalmic Treatment Market Size: 2021 VS 2028
2.2 Global Diabetes Associated Ophthalmic Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Diabetes Associated Ophthalmic Treatment Players in Global Market
3.2 Top Global Diabetes Associated Ophthalmic Treatment Companies Ranked by Revenue
3.3 Global Diabetes Associated Ophthalmic Treatment Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Associated Ophthalmic Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetes Associated Ophthalmic Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Associated Ophthalmic Treatment Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Associated Ophthalmic Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Associated Ophthalmic Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Diabetes Associated Ophthalmic Treatment Market Size Markets, 2021 & 2028
4.1.2 Dry Eye Syndrome
4.1.3 Glaucoma
4.1.4 Eye Allergy & Infection
4.1.5 Diabetic Retinopathy
4.1.6 Diabetic associated Macular Degeneration
4.1.7 Uveitis
4.1.8 Cataract
4.1.9 Diabetic Macular Edema
4.1.10 Others
4.2 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue & Forecasts
4.2.1 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue, 2017-2022
4.2.2 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue, 2023-2028
4.2.3 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Diabetes Associated Ophthalmic Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ophthalmic Centers
5.1.4 Ambulatory Surgical Centers
5.1.5 Others
5.2 By End User - Global Diabetes Associated Ophthalmic Treatment Revenue & Forecasts
5.2.1 By End User - Global Diabetes Associated Ophthalmic Treatment Revenue, 2017-2022
5.2.2 By End User - Global Diabetes Associated Ophthalmic Treatment Revenue, 2023-2028
5.2.3 By End User - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Diabetes Associated Ophthalmic Treatment Market Size, 2021 & 2028
6.2 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue & Forecasts
6.2.1 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue, 2017-2022
6.2.2 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue, 2023-2028
6.2.3 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028
6.3.2 US Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.3.3 Canada Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.3.4 Mexico Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028
6.4.2 Germany Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.3 France Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.4 U.K. Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.5 Italy Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.6 Russia Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.8 Benelux Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028
6.5.2 China Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.5.3 Japan Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.5.4 South Korea Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.5.6 India Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028
6.6.2 Brazil Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.6.3 Argentina Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028
6.7.2 Turkey Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.7.3 Israel Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.7.5 UAE Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Alcon
7.1.1 Alcon Corporate Summary
7.1.2 Alcon Business Overview
7.1.3 Alcon Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.1.4 Alcon Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.1.5 Alcon Key News
7.2 Johnson & Johnson Services, Inc.
7.2.1 Johnson & Johnson Services, Inc. Corporate Summary
7.2.2 Johnson & Johnson Services, Inc. Business Overview
7.2.3 Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.2.4 Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.2.5 Johnson & Johnson Services, Inc. Key News
7.3 Bausch Health
7.3.1 Bausch Health Corporate Summary
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.3.4 Bausch Health Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.3.5 Bausch Health Key News
7.4 F. Hoffmann-La Roche Ltd
7.4.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.4.2 F. Hoffmann-La Roche Ltd Business Overview
7.4.3 F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.4.5 F. Hoffmann-La Roche Ltd Key News
7.5 Allergan
7.5.1 Allergan Corporate Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.5.4 Allergan Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.5.5 Allergan Key News
7.6 Bayer AG
7.6.1 Bayer AG Corporate Summary
7.6.2 Bayer AG Business Overview
7.6.3 Bayer AG Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.6.4 Bayer AG Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.6.5 Bayer AG Key News
7.7 Santen Pharmaceutical Co. Ltd.
7.7.1 Santen Pharmaceutical Co. Ltd. Corporate Summary
7.7.2 Santen Pharmaceutical Co. Ltd. Business Overview
7.7.3 Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.7.4 Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.7.5 Santen Pharmaceutical Co. Ltd. Key News
7.8 Novartis AG
7.8.1 Novartis AG Corporate Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.8.4 Novartis AG Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.8.5 Novartis AG Key News
7.9 Pfizer, Inc.
7.9.1 Pfizer, Inc. Corporate Summary
7.9.2 Pfizer, Inc. Business Overview
7.9.3 Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.9.4 Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.9.5 Pfizer, Inc. Key News
7.10 Genentech, Inc.
7.10.1 Genentech, Inc. Corporate Summary
7.10.2 Genentech, Inc. Business Overview
7.10.3 Genentech, Inc. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.10.4 Genentech, Inc. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.10.5 Genentech, Inc. Key News
7.11 Carl Zeiss Meditec
7.11.1 Carl Zeiss Meditec Corporate Summary
7.11.2 Carl Zeiss Meditec Business Overview
7.11.3 Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.11.4 Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.11.5 Carl Zeiss Meditec Key News
7.12 Lumenis
7.12.1 Lumenis Corporate Summary
7.12.2 Lumenis Business Overview
7.12.3 Lumenis Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.12.4 Lumenis Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.12.5 Lumenis Key News
7.13 Ellex Medical Lasers Ltd.
7.13.1 Ellex Medical Lasers Ltd. Corporate Summary
7.13.2 Ellex Medical Lasers Ltd. Business Overview
7.13.3 Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.13.4 Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.13.5 Ellex Medical Lasers Ltd. Key News
7.14 IRIDEX Corp.
7.14.1 IRIDEX Corp. Corporate Summary
7.14.2 IRIDEX Corp. Business Overview
7.14.3 IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.14.4 IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.14.5 IRIDEX Corp. Key News
7.15 Topcon Corp.
7.15.1 Topcon Corp. Corporate Summary
7.15.2 Topcon Corp. Business Overview
7.15.3 Topcon Corp. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.15.4 Topcon Corp. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.15.5 Topcon Corp. Key News
7.16 Abbott Medical Optics
7.16.1 Abbott Medical Optics Corporate Summary
7.16.2 Abbott Medical Optics Business Overview
7.16.3 Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.16.4 Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.16.5 Abbott Medical Optics Key News
7.17 Quantel
7.17.1 Quantel Corporate Summary
7.17.2 Quantel Business Overview
7.17.3 Quantel Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.17.4 Quantel Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.17.5 Quantel Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Diabetes Associated Ophthalmic Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by End User
1.3 Global Diabetes Associated Ophthalmic Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL DIABETES ASSOCIATED OPHTHALMIC TREATMENT OVERALL MARKET SIZE
2.1 Global Diabetes Associated Ophthalmic Treatment Market Size: 2021 VS 2028
2.2 Global Diabetes Associated Ophthalmic Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Diabetes Associated Ophthalmic Treatment Players in Global Market
3.2 Top Global Diabetes Associated Ophthalmic Treatment Companies Ranked by Revenue
3.3 Global Diabetes Associated Ophthalmic Treatment Revenue by Companies
3.4 Top 3 and Top 5 Diabetes Associated Ophthalmic Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Diabetes Associated Ophthalmic Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Diabetes Associated Ophthalmic Treatment Players in Global Market
3.6.1 List of Global Tier 1 Diabetes Associated Ophthalmic Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Diabetes Associated Ophthalmic Treatment Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Diabetes Associated Ophthalmic Treatment Market Size Markets, 2021 & 2028
4.1.2 Dry Eye Syndrome
4.1.3 Glaucoma
4.1.4 Eye Allergy & Infection
4.1.5 Diabetic Retinopathy
4.1.6 Diabetic associated Macular Degeneration
4.1.7 Uveitis
4.1.8 Cataract
4.1.9 Diabetic Macular Edema
4.1.10 Others
4.2 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue & Forecasts
4.2.1 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue, 2017-2022
4.2.2 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue, 2023-2028
4.2.3 By Type - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Diabetes Associated Ophthalmic Treatment Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ophthalmic Centers
5.1.4 Ambulatory Surgical Centers
5.1.5 Others
5.2 By End User - Global Diabetes Associated Ophthalmic Treatment Revenue & Forecasts
5.2.1 By End User - Global Diabetes Associated Ophthalmic Treatment Revenue, 2017-2022
5.2.2 By End User - Global Diabetes Associated Ophthalmic Treatment Revenue, 2023-2028
5.2.3 By End User - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Diabetes Associated Ophthalmic Treatment Market Size, 2021 & 2028
6.2 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue & Forecasts
6.2.1 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue, 2017-2022
6.2.2 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue, 2023-2028
6.2.3 By Region - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028
6.3.2 US Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.3.3 Canada Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.3.4 Mexico Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028
6.4.2 Germany Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.3 France Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.4 U.K. Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.5 Italy Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.6 Russia Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.4.8 Benelux Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028
6.5.2 China Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.5.3 Japan Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.5.4 South Korea Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.5.6 India Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028
6.6.2 Brazil Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.6.3 Argentina Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028
6.7.2 Turkey Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.7.3 Israel Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
6.7.5 UAE Diabetes Associated Ophthalmic Treatment Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Alcon
7.1.1 Alcon Corporate Summary
7.1.2 Alcon Business Overview
7.1.3 Alcon Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.1.4 Alcon Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.1.5 Alcon Key News
7.2 Johnson & Johnson Services, Inc.
7.2.1 Johnson & Johnson Services, Inc. Corporate Summary
7.2.2 Johnson & Johnson Services, Inc. Business Overview
7.2.3 Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.2.4 Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.2.5 Johnson & Johnson Services, Inc. Key News
7.3 Bausch Health
7.3.1 Bausch Health Corporate Summary
7.3.2 Bausch Health Business Overview
7.3.3 Bausch Health Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.3.4 Bausch Health Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.3.5 Bausch Health Key News
7.4 F. Hoffmann-La Roche Ltd
7.4.1 F. Hoffmann-La Roche Ltd Corporate Summary
7.4.2 F. Hoffmann-La Roche Ltd Business Overview
7.4.3 F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.4.4 F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.4.5 F. Hoffmann-La Roche Ltd Key News
7.5 Allergan
7.5.1 Allergan Corporate Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.5.4 Allergan Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.5.5 Allergan Key News
7.6 Bayer AG
7.6.1 Bayer AG Corporate Summary
7.6.2 Bayer AG Business Overview
7.6.3 Bayer AG Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.6.4 Bayer AG Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.6.5 Bayer AG Key News
7.7 Santen Pharmaceutical Co. Ltd.
7.7.1 Santen Pharmaceutical Co. Ltd. Corporate Summary
7.7.2 Santen Pharmaceutical Co. Ltd. Business Overview
7.7.3 Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.7.4 Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.7.5 Santen Pharmaceutical Co. Ltd. Key News
7.8 Novartis AG
7.8.1 Novartis AG Corporate Summary
7.8.2 Novartis AG Business Overview
7.8.3 Novartis AG Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.8.4 Novartis AG Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.8.5 Novartis AG Key News
7.9 Pfizer, Inc.
7.9.1 Pfizer, Inc. Corporate Summary
7.9.2 Pfizer, Inc. Business Overview
7.9.3 Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.9.4 Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.9.5 Pfizer, Inc. Key News
7.10 Genentech, Inc.
7.10.1 Genentech, Inc. Corporate Summary
7.10.2 Genentech, Inc. Business Overview
7.10.3 Genentech, Inc. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.10.4 Genentech, Inc. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.10.5 Genentech, Inc. Key News
7.11 Carl Zeiss Meditec
7.11.1 Carl Zeiss Meditec Corporate Summary
7.11.2 Carl Zeiss Meditec Business Overview
7.11.3 Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.11.4 Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.11.5 Carl Zeiss Meditec Key News
7.12 Lumenis
7.12.1 Lumenis Corporate Summary
7.12.2 Lumenis Business Overview
7.12.3 Lumenis Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.12.4 Lumenis Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.12.5 Lumenis Key News
7.13 Ellex Medical Lasers Ltd.
7.13.1 Ellex Medical Lasers Ltd. Corporate Summary
7.13.2 Ellex Medical Lasers Ltd. Business Overview
7.13.3 Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.13.4 Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.13.5 Ellex Medical Lasers Ltd. Key News
7.14 IRIDEX Corp.
7.14.1 IRIDEX Corp. Corporate Summary
7.14.2 IRIDEX Corp. Business Overview
7.14.3 IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.14.4 IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.14.5 IRIDEX Corp. Key News
7.15 Topcon Corp.
7.15.1 Topcon Corp. Corporate Summary
7.15.2 Topcon Corp. Business Overview
7.15.3 Topcon Corp. Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.15.4 Topcon Corp. Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.15.5 Topcon Corp. Key News
7.16 Abbott Medical Optics
7.16.1 Abbott Medical Optics Corporate Summary
7.16.2 Abbott Medical Optics Business Overview
7.16.3 Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.16.4 Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.16.5 Abbott Medical Optics Key News
7.17 Quantel
7.17.1 Quantel Corporate Summary
7.17.2 Quantel Business Overview
7.17.3 Quantel Diabetes Associated Ophthalmic Treatment Major Product Offerings
7.17.4 Quantel Diabetes Associated Ophthalmic Treatment Revenue in Global Market (2017-2022)
7.17.5 Quantel Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Diabetes Associated Ophthalmic Treatment Market Opportunities & Trends in Global Market
Table 2. Diabetes Associated Ophthalmic Treatment Market Drivers in Global Market
Table 3. Diabetes Associated Ophthalmic Treatment Market Restraints in Global Market
Table 4. Key Players of Diabetes Associated Ophthalmic Treatment in Global Market
Table 5. Top Diabetes Associated Ophthalmic Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetes Associated Ophthalmic Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetes Associated Ophthalmic Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetes Associated Ophthalmic Treatment Product Type
Table 9. List of Global Tier 1 Diabetes Associated Ophthalmic Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Associated Ophthalmic Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By End User – Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By End User - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By End User - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Alcon Corporate Summary
Table 31. Alcon Diabetes Associated Ophthalmic Treatment Product Offerings
Table 32. Alcon Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Services, Inc. Corporate Summary
Table 34. Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 35. Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bausch Health Corporate Summary
Table 37. Bausch Health Diabetes Associated Ophthalmic Treatment Product Offerings
Table 38. Bausch Health Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 39. F. Hoffmann-La Roche Ltd Corporate Summary
Table 40. F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Product Offerings
Table 41. F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Allergan Corporate Summary
Table 43. Allergan Diabetes Associated Ophthalmic Treatment Product Offerings
Table 44. Allergan Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bayer AG Corporate Summary
Table 46. Bayer AG Diabetes Associated Ophthalmic Treatment Product Offerings
Table 47. Bayer AG Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Santen Pharmaceutical Co. Ltd. Corporate Summary
Table 49. Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 50. Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Novartis AG Corporate Summary
Table 52. Novartis AG Diabetes Associated Ophthalmic Treatment Product Offerings
Table 53. Novartis AG Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer, Inc. Corporate Summary
Table 55. Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 56. Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Genentech, Inc. Corporate Summary
Table 58. Genentech, Inc. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 59. Genentech, Inc. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Carl Zeiss Meditec Corporate Summary
Table 61. Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Product Offerings
Table 62. Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Lumenis Corporate Summary
Table 64. Lumenis Diabetes Associated Ophthalmic Treatment Product Offerings
Table 65. Lumenis Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Ellex Medical Lasers Ltd. Corporate Summary
Table 67. Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 68. Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 69. IRIDEX Corp. Corporate Summary
Table 70. IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 71. IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Topcon Corp. Corporate Summary
Table 73. Topcon Corp. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 74. Topcon Corp. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Abbott Medical Optics Corporate Summary
Table 76. Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Product Offerings
Table 77. Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Quantel Corporate Summary
Table 79. Quantel Diabetes Associated Ophthalmic Treatment Product Offerings
Table 80. Quantel Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 1. Diabetes Associated Ophthalmic Treatment Market Opportunities & Trends in Global Market
Table 2. Diabetes Associated Ophthalmic Treatment Market Drivers in Global Market
Table 3. Diabetes Associated Ophthalmic Treatment Market Restraints in Global Market
Table 4. Key Players of Diabetes Associated Ophthalmic Treatment in Global Market
Table 5. Top Diabetes Associated Ophthalmic Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Diabetes Associated Ophthalmic Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Diabetes Associated Ophthalmic Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Diabetes Associated Ophthalmic Treatment Product Type
Table 9. List of Global Tier 1 Diabetes Associated Ophthalmic Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Diabetes Associated Ophthalmic Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By End User – Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By End User - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By End User - Diabetes Associated Ophthalmic Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Alcon Corporate Summary
Table 31. Alcon Diabetes Associated Ophthalmic Treatment Product Offerings
Table 32. Alcon Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Services, Inc. Corporate Summary
Table 34. Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 35. Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bausch Health Corporate Summary
Table 37. Bausch Health Diabetes Associated Ophthalmic Treatment Product Offerings
Table 38. Bausch Health Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 39. F. Hoffmann-La Roche Ltd Corporate Summary
Table 40. F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Product Offerings
Table 41. F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Allergan Corporate Summary
Table 43. Allergan Diabetes Associated Ophthalmic Treatment Product Offerings
Table 44. Allergan Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Bayer AG Corporate Summary
Table 46. Bayer AG Diabetes Associated Ophthalmic Treatment Product Offerings
Table 47. Bayer AG Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Santen Pharmaceutical Co. Ltd. Corporate Summary
Table 49. Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 50. Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Novartis AG Corporate Summary
Table 52. Novartis AG Diabetes Associated Ophthalmic Treatment Product Offerings
Table 53. Novartis AG Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer, Inc. Corporate Summary
Table 55. Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 56. Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Genentech, Inc. Corporate Summary
Table 58. Genentech, Inc. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 59. Genentech, Inc. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Carl Zeiss Meditec Corporate Summary
Table 61. Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Product Offerings
Table 62. Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Lumenis Corporate Summary
Table 64. Lumenis Diabetes Associated Ophthalmic Treatment Product Offerings
Table 65. Lumenis Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Ellex Medical Lasers Ltd. Corporate Summary
Table 67. Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 68. Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 69. IRIDEX Corp. Corporate Summary
Table 70. IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 71. IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Topcon Corp. Corporate Summary
Table 73. Topcon Corp. Diabetes Associated Ophthalmic Treatment Product Offerings
Table 74. Topcon Corp. Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Abbott Medical Optics Corporate Summary
Table 76. Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Product Offerings
Table 77. Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Quantel Corporate Summary
Table 79. Quantel Diabetes Associated Ophthalmic Treatment Product Offerings
Table 80. Quantel Diabetes Associated Ophthalmic Treatment Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Diabetes Associated Ophthalmic Treatment Segment by Type in 2021
Figure 2. Diabetes Associated Ophthalmic Treatment Segment by End User in 2021
Figure 3. Global Diabetes Associated Ophthalmic Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetes Associated Ophthalmic Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Associated Ophthalmic Treatment Revenue in 2021
Figure 8. By Type - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 9. By End User - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 12. US Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 24. China Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Alcon Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bausch Health Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allergan Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bayer AG Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis AG Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Genentech, Inc. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Lumenis Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Topcon Corp. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Quantel Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Diabetes Associated Ophthalmic Treatment Segment by Type in 2021
Figure 2. Diabetes Associated Ophthalmic Treatment Segment by End User in 2021
Figure 3. Global Diabetes Associated Ophthalmic Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Diabetes Associated Ophthalmic Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Diabetes Associated Ophthalmic Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Diabetes Associated Ophthalmic Treatment Revenue in 2021
Figure 8. By Type - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 9. By End User - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 12. US Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 24. China Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Diabetes Associated Ophthalmic Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Diabetes Associated Ophthalmic Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Alcon Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Services, Inc. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bausch Health Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. F. Hoffmann-La Roche Ltd Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allergan Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Bayer AG Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Santen Pharmaceutical Co. Ltd. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Novartis AG Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer, Inc. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Genentech, Inc. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Carl Zeiss Meditec Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Lumenis Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Ellex Medical Lasers Ltd. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. IRIDEX Corp. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Topcon Corp. Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Abbott Medical Optics Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Quantel Diabetes Associated Ophthalmic Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
